Lipoprotein-X

References

• Kunkel H. G., Slater R. J. Lipoprotein patterns of serum obtained by zone electrophoresis. J. Clin. Invest. 1952; 31: 677
   PubMed Web of Science ®Google Scholar
• Russ E. M., Raymunt J., Barr D. P. Lipoproteins in primary biliary cirrhosis. J. Clin. Invest. 1956; 35: 133
   PubMed Web of Science ®Google Scholar
• Switzer S. Plasma lipoproteins in liver disease. I. Immunologically distinct low-density lipoproteins in patients with biliary obstruction. J. Clin. Invest. 1967; 46: 1855
   PubMed Web of Science ®Google Scholar
• Seidel D., Alaupovic P., Furman R. H. A lipoprotein characterizing obstructive jaundice. I. Separation and identification of lipoproteins in jaundiced subjects, J. Clin. Invest. 1969; 48: 1211
   Google Scholar
• Torsvik H., Berg K., Magnani H. N., McConathy W. J., Alaupovic P., Gjone E. Identification of the abnormal cholestatic lipoprotein (LP-X) in familial lecithinolesterol acyltransferase deficiency. FEBS Lett. 1972; 24: 165
   PubMed Web of Science ®Google Scholar
• Burstein M., Samaille J. Sur un dosage rapide du cholesterol lie aux α-I et aux β-lipoproteins du serum. Clin. Chim. Acta 1960; 5: 609
   PubMed Web of Science ®Google Scholar
• Burstein M. Précipitation sélective des lipoproteines sériques defaible densité par l'heparine en présence du chlorure de magnésium et de saccharose. C. R. Mens. Seances. Acad. Sci. Outre-Mer. 1962; 255: 605
   PubMedGoogle Scholar
• Cohn E. J., Gurd F. R. N., Surgenor D. M., Barnes B. A., Brown R. K., Derouaux G., Gillespie J. M., Kahnt F. W., Lever W. F., Liu C. H., Mittelman D., Mouton R. F., Schmid K., Uroma E. A system for the separation of the components of human blood: quantitative procedures for the separation of the protein components of human plasma. J. Am. Chem. Soc 1950; 72: 465
   Web of Science ®Google Scholar
• Danielsson B., Johansson B. G., Petersson B. G. Separation of lipoprotein X and β-lipoprotein by zonal centrifugation or hydroxyapatite chromatography. Clin. Chim. Acta 1973; 47: 365
   PubMedGoogle Scholar
• Patsch J. R., Patsch W., Sailer S., Braunsteiner H. Isolation and partial characterization of two abnormal human plasma lipoproteins: LP-X1, and LP-X2. Biochim. Biophys. Acta 1976; 434: 419
   PubMedGoogle Scholar
• Patsch J. R., Aune K. C., Gotto A. M., Jr., Morrisett J. D. Isolation, chemical characterization, and biophysical properties of three different abnormal lipoproteins: LP-X, LP-X2, and LP-X3. J. Biol. Chem. 1977; 252: 2113
   PubMedGoogle Scholar
• Neubeck W., Seidel D. Direct method for measuring lipoprotein-X in serum. Clin. Chem. (Winston-Salem, NC) 1975; 21: 853
   PubMed Web of Science ®Google Scholar
• Müller P., Fauser U., Fellin R., Wieland H., Seidel D. Isolation and characterization of lipoprotein-X (LP-X) from canine. FEBS Lett. 1973; 38: 53
   PubMed Web of Science ®Google Scholar
• Seidel D., Buff H. U., Fauser U., Bleyl U. On the metabolism of lipoprotein-X (LP-X). Clin. Chim. Acta 1976; 66: 195
   PubMed Web of Science ®Google Scholar
• Müller P., Baggio G., Barth H. O., Wieland H., Anari M., Seidel D. Isolation and characterization of lipoprotein-X from the pig. Clin. Chim. Acta 1977; 80: 487
   PubMedGoogle Scholar
• Seidel D., Alaupovic P., Furman R. H., McConathy W. J. A lipoprotein characterizing obstructive jaundice. II. Isolation and partial characterization of the protein moieties of low density lipoproteins. J. Clin. Invest. 1970; 49: 2396
   PubMed Web of Science ®Google Scholar
• Skipski V. P., Barclay M., Barclay R. K., Fetzer V. A., Good J. J., Archibald F. M. Lipid composition of human serum lipoproteins. Biochem. J. 1967; 104: 340
   PubMed Web of Science ®Google Scholar
• Burstein M., Caroli J. Lipoprotèines sériques anormales au cours de certains icteres par rétention. Rev. Fr. Etud. Clin. Biol. 1967; 12: 898
   PubMedGoogle Scholar
• Gustafson A., Alaupovic P., Furman R. H. Studies of the composition and structure of serum lipoproteins: isolation, purification and characterization of very low density lipoproteins of human serum. Biochemistry 1965; 4: 596
   PubMed Web of Science ®Google Scholar
• Shore B., Shore V. Isolation and characterization of polypeptides of human serum lipoproteins. Biochemistry 1969; 8: 4510
   PubMed Web of Science ®Google Scholar
• Brown W. V., Levy R. I., Fredrickson D. S. Studies of the proteins in human plasma very low density lipoproteins. J. Biol. Chem. 1969; 244: 5687
   PubMed Web of Science ®Google Scholar
• Jackson R. L., Sparrow J. T., Baker H. N., Morrisett J. D., Taunton O. D., Gotto A. M. The primary structure of apolipoprotein-serine. J. Biol. Chem. 1974; 249: 5308
   PubMed Web of Science ®Google Scholar
• Shulman R. S., Herbert P. N., Wehrly K., Fredrickson D. S. The complete amino acid sequence of C-1 (apoLP-Ser), an apolipoprotein from human very low density lipoproteins. J. Biol. Chem. 1975; 250: 182
   PubMed Web of Science ®Google Scholar
• Brown W. V., Levy R. I., Fredrickson D. S. Further characterization of apolipoproteins from the human plasma very low density lipoproteins. J. Biol. Chem. 1970; 245: 6588
   PubMedGoogle Scholar
• Jackson R. L., Morrisett J. D., Sparrow J. T., Segrest J. P., Pownall H. J., Smith L. C., Hoff H. F., Gotto A. M. The interaction of apolipoprotein-serine with phosphatidylcholine. J. Biol. Chem. 1974; 249: 5314
   PubMed Web of Science ®Google Scholar
• Brewer H. B., Shulman R., Herbert P., Ronan R., Wehrly K. The complete amino acid sequence of alanine lipoprotein (apoC-3), an apolipoprotein from human plasma very low density lipoproteins. J. Biol. Chem. 1974; 249: 4975
   PubMed Web of Science ®Google Scholar
• Shulman R. S., Herbert P. N., Fredrickson D. S., Wehrly K., Brewer H. B. Isolation and alignment of the tryptic peptides of alanine apolipoprotein, an apolipoprotein from human plasma very low density lipoproteins. J. Biol. Chem. 1974; 249: 4969
   PubMedGoogle Scholar
• Morrisett J. D., Jackson R. L., Gotto A. M., Jr. Lipid-protein interactions in the plasma lipoproteins. Biochim. Biophys. Acta 1977; 472: 93
   PubMed Web of Science ®Google Scholar
• Segrest J. P., Jackson R. L., Morrisett J. D., Gotto A. M. A molecular theory of lipid-protein interactions in the plasma lipoproteins. FEBS Lett. 1974; 38: 247
   PubMed Web of Science ®Google Scholar
• Andrews A. L., Atkinson D., Barratt M. D., Finer E. G., Hauser H., Henry R., Leslie R. B., Owens N. L., Phillips M. C., Robertson R. N. Interaction of apoprotein from porcine high-density lipoprotein with dimyristoyl lecithin. II. Nature of lipid-protein interaction. Eur. J. Biochem. 1976; 60: 549
   Google Scholar
• Assmann G., Brewer H. B., Jr. A molecular model of high density lipoproteins. Proc. Natl. Acad. Sci. U.S.A. 1974; 71: 1534
   PubMedGoogle Scholar
• Sparrow J. T., Morrisett J. D., Pownall H. J., Jackson R. L., Gotto A. M. Peptides: Chemistry, Structure and Biology, R. Walter, J. Meienhofer. Ann Arbor Science, Michigan 1975; 597
   Google Scholar
• Quartfordt S. H., Oelschalaeger H., Krigbaum W. R. Liquid crystalline lipid in the plasma of humans with biliary obstruction. J. Clin. Invest. 1972; 51: 1979
   PubMedGoogle Scholar
• Fielding C. J., Shore V. G., Fielding P. E. A protein cofactor of lecithinolesterol acyltransferase. Biochem. Biophys. Res. Comm. 1972; 46: 1493
   PubMed Web of Science ®Google Scholar
• Utermann G., Menzel H. J., Langer K. H. Peptide composition of an abnormal high density lipoprotein (LP-E) occurring in LCAT-deficient plasma. FEBS Lett. 1977; 45: 29
   Google Scholar
• Skipski V. P. Blood Lipids and Lipoproteins: Quantitation, Composition and Metabolism, G. J. Nelson. John Wiley & Sons, New York 1972; 471
   Google Scholar
• Glomset J. A. The plasma lecithinsolesterol acyltransferase reaction. J. Lipid Res. 1968; 9: 155
   PubMed Web of Science ®Google Scholar
• Calandra S., Martin M. J., McIntyre N. Plasma lecithinolesterol acyltransferase activity in liver disease. Eur. J. Clin. Invest. 1971; 1: 352
   PubMed Web of Science ®Google Scholar
• Soutar A. K., Pownall H. J., Hu A. S., Smith L. C. Phase transitions in bilamellar vesicles. Measurements by pyrene excimer fluorescence and effect on transacylation by lecithinolesterol acyltransferase. Biochemistry 1974; 13: 2828
   PubMed Web of Science ®Google Scholar
• Seidel D., Agostini G., Müller P. Structure of an abnormal plasma lipoprotein (LP-X) characterizing obstructive jaundice. Biochim. Biophys. Acta 1972; 260: 147
   Google Scholar
• Morrisett J. D., Gallagher J. G., Aune K. C., Gotto A. M., Jr. Structure of the major complex formed by interaction of phosphatidylcholine bilamellar vesicles and apolipoprotein-alanine (APO-C-III). Biochemistry 1974; 13: 4765
   PubMedGoogle Scholar
• Kostner G. M., Patsch J. R., Sailer S., Braunsteiner H., Holasek A. Polypeptide distribution of the main lipoprotein density classes separated from human plasma by rate zonal ultracentrifugation. Eur. J. Biochem. 1974; 45: 611
   PubMedGoogle Scholar
• Scanu A., Lewis A. L., Bumpus F. M. Separation and characterization of the protein moiety of human α-lipoprotein. Arch. Biochem. Biophys. 1958; 74: 390
   PubMedGoogle Scholar
• Magnani H., Alaupovic P., Seidel D. Conf. Serum Lipoproteins, GrazAustria, October, 21 to 231973, Abstr. B16
   Google Scholar
• Seidel D. A new immunochemical technique for a rapid semiquantitative determination of the abnormal lipoprotein (LP-X) characterizing cholestasis. Clin. Chim. Acta 1971; 31: 225
   PubMed Web of Science ®Google Scholar
• Kostner G. M., Petek W., Holazek A. Immunochemical measurement of lipoprotein-X. Clin. Chem. (Winston-Salem, NC) 1974; 20: 676
   PubMed Web of Science ®Google Scholar
• Magnani H. N., Alaupovic P. A method for the quantitative determination of the abnormal lipoprotein (LP-X) of obstructive jaundice. Clin. Chim. Acta 1972; 38: 405
   PubMed Web of Science ®Google Scholar
• Prexyl H. J., Petek W. Die bedeutung des lipoprotein-X und der serum cholesterase in der praoperativen diagnostik des Verschulussikterus. Chirung 1973; 44: 310
   PubMedGoogle Scholar
• Mancini G., Caxbonara A., Heremans J. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 1965; 2: 235
   PubMedGoogle Scholar
• Laurell C. B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal. Biochem. 1966; 15: 45
   PubMed Web of Science ®Google Scholar
• Svendsen P. J., Axelsen N. H. A modified antigen-antibody crossed electrophoresis characterizing the specificity and titer of human precipitines against “Candida albicans”. J. Immunol. Methods 1972; 1: 169
   PubMedGoogle Scholar
• Pearlstein E., Aladjem F. Subpopulations of human serum very low density lipoproteins. Biochemistry 1972; 11: 2553
   PubMedGoogle Scholar
• Kostner G., Alaupovic P. Studies of the composition and structure of plasma lipoproteins. Separation and quantification of the lipoprotein families occurring in the high density lipoproteins of human plasma. Biochemistry 1972; 11: 3419
   PubMed Web of Science ®Google Scholar
• Ritland S. A method for quantitative determination of the abnormal lipoprotein of cholestasis, LP-X. Clin. Chim. Acta. 1974; 55: 359
   PubMed Web of Science ®Google Scholar
• Wieland H., Seidel D. Eine neue und verein fachte methode zum nachweis des LP-X eines cholestasespezifischen lipoproteins. Dtsch. Med. Wochenschr. 1973; 98: 1474
   PubMed Web of Science ®Google Scholar
• Forte T., Nichols A. V. Application of Electron microscopy to the study of plasma lipoprotein structure. Adv. Lipid. Res. 1972; 10: 1
   PubMedGoogle Scholar
• Tardieu A., Mateu L., Sardet C., Weiss B., Luzzati V., Agerbeck L., Scanu A. M. Structure of human serum lipoproteins in solution, II. Small angle X-ray scattering study of HDL and LDL. J. Mol. Biol. 1976; 101: 129
   PubMed Web of Science ®Google Scholar
• Laggner P., Müller K., Kratky O., Kostner G. M., Holasek A. X-ray small angle scattering of human plasma lipoproteins. J. Colloid Interface. Sci. 1976; 55: 102
   Google Scholar
• Laggner P., Degovics G., Müller K. W., Glatter O., Kratky O., Kostner G., Holasek A. Molecular packing and fluidity of lipids in human serum low density lipoproteins. Hoppe-Seyler's Z. Physiol. Chem. 1977; 358: 771
   PubMedGoogle Scholar
• Lecuyer H., Dervichian D. G. Structure of aqueous mixtures of lecithin and cholesterol. J. Mol. Biol. 1969; 45: 39
   PubMed Web of Science ®Google Scholar
• Utermann G., Schoenborn W., Langer K. H., Dieker P. Lipopròteins in LCAT-deficiency. Humangenetik 1972; 16: 295
   PubMedGoogle Scholar
• Kostner G. M., Laggner P., Prexl H. J., Holasek A., Ingolic E., Geymayer W. Investigation of the abnormal low density lipoproteins occurring in patients with obstructive jaundice. Biochem. J. 1976; 157: 401
   PubMedGoogle Scholar
• Hamilton R. L., Havel R. J., Kane J. P., Blaurock A. E., Sata T. Cholestasis: lamellar structure of the abnormal human serum lipoprotein. Science 1971; 172: 475
   PubMed Web of Science ®Google Scholar
• Glomset J. A., Nichols A. V., Norum K. R., King W., Forte T. Plasma lipoproteins in familial lecithinolesterol acyltransferase deficiency. Further studies of very low and low density lipoprotein abnormalities. J. Clin. Invest. 1973; 52: 1078
   PubMed Web of Science ®Google Scholar
• Seidel D., Agostini B., Müller P. Structure of an abnormal plasma lipoprotein (LP-X) characterizing obstructive jaundice. Biochim. Biophys. Acta 1972; 260: 146
   PubMed Web of Science ®Google Scholar
• Laggner P., Glatter O., Muller K., Kratky O., Kostner G., Holasek A. The lipid bilayer structure of the abnormal human plasma lipoprotein X. An X-ray small-angle-scattering study. Eur. J. Biochem. 1977; 77: 165
   PubMedGoogle Scholar
• Papahadjopoulos D., Miller N. Phospholipid model membranes. I. Structural characteristics of hydrated liquid crystals. Biochim. Biophys. Acta 1967; 135: 624
   PubMed Web of Science ®Google Scholar
• Hauser H., Kostner G., Müller M., Skrabol P. Structure and morphology of abnormal serum lipoprotein-X. Biochim. Biophys. Acta 1977; 489: 247
   PubMedGoogle Scholar
• Jonas A. Phosphatidyl choline interaction with bovine serum albumin: effect of the physical slate of the lipid on protein lipid complex formation. Biochem. Biophys. Res. Commun. 1975; 64: 1003
   PubMedGoogle Scholar
• Jonas A. Interaction of phosphatidylcholine with bovine serum albumin. Specificity and properties of the complexes. Biochim. Biophys. Acta 1976; 427: 325
   PubMedGoogle Scholar
• Verkleij A. P., Nauta I. L. D., Werre J. M., Mandersloot J. G., Reinders B., Ververgaert P. H. J. T., DeGier J. The fusion of abnormal plasma lipoprotein (LP-X) and the erythrocyte membrane in patients with cholestasis studied by electron microscopy. Biochim. Biophys. Acta 1976; 436: 366
   PubMedGoogle Scholar
• Brocklehurst D., Lathe G. H., Aparico S. R. Serum alkaline phosphatase, nucleotide pyrophosphatase, 5′-nucleotidase and lipoprotein-X in cholestasis. Clin. Chim. Acta 1976; 67: 269
   PubMed Web of Science ®Google Scholar
• Degenaar C. P., Thijssen C., Van der Wal G., Berends G. T. Electrophoresis of γ-Glutamyl transpeptidase on cellogel. The appearance of the α2-β band in positive LP-X sera. Clin. Chim. Acta 1976; 67: 79
   PubMed Web of Science ®Google Scholar
• De broe M. E., Borgers M., Wienie R. J. The separation and characterization of liver plasma membrane fragments circulating in the blood of patients with cholestasis. Clin. Chim. Acta 1975; 59: 369
   PubMed Web of Science ®Google Scholar
• De broe M. E., Wieme R. J. The cholestatic doublet of alkaline phosphatase: its origin and clinical significance. 3rd Int. Conf. on Isoenzymes, C. Markert. Academic Press, New York 1974; 799
   Google Scholar
• Jennings R. C., Brocklehurst D., Hirst M. A comparative study of alkaline phosphates enzymes using starch-gel electrophoresis and sephadex gel-filtration with special reference to high molecular weight enzymes. Clin. Chim. Acta 1970; 30: 509
   PubMed Web of Science ®Google Scholar
• Yaé Y., Narayanan S., Okochi K. Studies on serum alkaline phosphatase associated with Lipoprotein-X in patients with obstructive jaundice. Clin. Chem. (Winston-Salem, NC) 1977; 1156, (Abstr. 202)
   Google Scholar
• Magnani H. N., McConathy W. J., Alaupovic P. Identification of the abnormal cholestatic Lipoprotein (LP-X) in familial lecithinolesterol acyltransferase deficiency. FEBS Lett. 1972; 24: 165
   PubMedGoogle Scholar
• Seidel D., Gjone E., Blomhoff J. P., Geisen H. P. Plasma lipoproteins in patients with familial plasma lecithinolesterol acyltransferase (LCAT) deficiency. Studies on the apolipoprotein composition of isolated fractions with identification of LP-X, in Lipid metabolism, obesity and diabetes mellitus: impact upon artherosclerosis. International symposium, Hormone and Metabolic Research. April, 1972; 6, 11, Suppl., 4
   Google Scholar
• Kostner G. M., Laggner P., Prexl H. J., Holasek A., Ingolic E., Geymayer W. Investigation of the abnormal low-density lipoproteins occurring in patients with obstructive jaundice. Biochem. J. 1976; 157: 401
   PubMedGoogle Scholar
• Forte T., Nichols A., Glomset J., Norum K. The ultrastructure of plasma lipoproteins in lecithinolesterol acyltransferase deficiency. Scand. J. Clin. Lab. Invest. 1974; 33(Suppl. 137)321
   Google Scholar
• Simon J. B., Scheig R. N. Serum cholesterol esterification in liver disease. Importance of lecithinolesterol acyltransferase. N. Engl. J. Med. 1970; 283: 841
   PubMed Web of Science ®Google Scholar
• Calandra S., Martin M. J., McIntyre N. Plasma lecithinolesterol acyltransferase activity in liver disease. Eur. J. Clin. Invest. 1971; 1: 352
   PubMed Web of Science ®Google Scholar
• McIntyre N., Calandra S., Pearson A. J. G. Lipid and lipoprotein abnormalities in liver disease: the possible role of lecithinolesterol acyltransferase deficiency. Scand. J. Clin. Lab. Invest. 1974; 33(Suppl. 137)115
   Google Scholar
• Simon J. B. Lecithinolesterol acyltransferase in human liver disease. Scand. J. Clin. Lab. Invest. 1974; 33(Suppl. 137)107
   Google Scholar
• Magnani H. N. The influence of LP-X and other lipoproteins associated with hepatic dysfunction on the activity of lecithinolesterol acyltransferase. Biochim. Biophys. Acta 1976; 450: 390
   PubMedGoogle Scholar
• Patsch W., Patsch J. R., Sailer S. In vitro degradation of LP-X by normal plasma. Eur. J. Clin. Invest. 1974; 33(Suppl. 137)107
   Google Scholar
• Ritland S., Gjone E. Quantitative studies of Lipoprotein-X in familial lecithinolesterol acyltransferase deficiency and during cholesterol esterification. Clin. Chim. Acta 1975; 59: 109
   PubMed Web of Science ®Google Scholar
• Wengeler H., Seidel D. Does Lipoprotein-X (LP-X) act as a substrate for the lecithinolesterol acyltransferance (LCAT)?. Clin. Chim. Acta 1973; 45: 429
   PubMed Web of Science ®Google Scholar
• Patsch J. R., Soutar A. K., Morrisett J. D., Gotto A. M., Jr., Smith L. C. Lipoprotein-X: a substrate for lecithinolesterol acyltransferase. Eur. J. Clin. Invest. 1977; 7: 213
   PubMedGoogle Scholar
• Gjone E., Norum K. A. Plasma lecithin-cholesterol acyltransferase and erythrocyte lipids in liver disease. Acta Med. Scand. 1970; 186: 153
   Google Scholar
• Michael B., Ritter U. The diagnostic importance of low density lipoprotein (LP-X) for the diagnosis of cholestasis. Z. Gastroenterol. 1976; 14: 556
   PubMedGoogle Scholar
• Magnani H. N., Alaupovic P. Utilization of the quantitative assay of lipoprotein-X in the differential diagnosis of extrahepatic obstructive jaundice and intrahepatic disease. Gastroenterology 1976; 71: 87
   PubMedGoogle Scholar
• Tanno H., Fay O., Palazzi J., Pedrana R., Yager E., Roncoroni M. LP-X in cholestasis. Acta Hepato-Gastroenterol. 1975; 22: 289
   PubMedGoogle Scholar
• Mayr K. The significance of lipoprotein-X in the diagnosis of obstructive jaundice: comparison with other biochemical tests. Dtsch. Med. Wochenschr. 1975; 100: 2193
   PubMedGoogle Scholar
• Ritland S. Quantitative determination of the abnormal lipoprotein of cholestasis, LP-X, in liver disease. Scand. J. Gastroenterol. 1975; 10: 5
   PubMed Web of Science ®Google Scholar
• Pirola R., Thompson G., Cordess C. Diagnostic value of serum lipoprotein-X in jaundice. Med. J. Aust. 1976; 1: 886
   PubMedGoogle Scholar
• Lebacg E. G., Heller F. LP-X test in sarcoidosis patients with liver involvement. Comparison with other liver function tests. Ann. N. Y. Acad. Sci. 1976; 278: 439
   PubMedGoogle Scholar
• Milewski B., Palynyczko Z. Significance of serum Lipoprotein-X (LP-X) determination for the diagnosis of cholestasis in chronic liver diseases. Pol. Med. Sci. Hist. Bull 1975; 15: 551
   PubMedGoogle Scholar
• Degenaar C. P., Thijssen C., Van der Wal G., Berends G. T. Electrophoresis of y-Glutamyl transpeptidase on cellogel. The appearance of the α2-β band in positive LP-X sera. Clin. Chim. Acta 1976; 67: 79
   PubMed Web of Science ®Google Scholar
• Witt I., Ober M. LP-X in newborns: increased incidence of positive tests without cholestasis
   Google Scholar
• Campbell D. P., Williams R. G. Identification of the jaundiced infant who is likely to recover without surgical intervention. Ann. Surg. 1976; 184: 89
   PubMedGoogle Scholar
• Baldi A., D'Aniello P., Giuliano G., Colucci M., De Crescenzo A. Behavior of lipoprotein-X (LP-X) in viral hepatitis. Quad. Sclavo. Diagn. Clin. Lab. 1975; 11: 122
   PubMedGoogle Scholar
• Samside G., Lundborg H., Ivarsson S., Gustafson A. On the occurrence of lipoprotein-X in non hemolytic jaundice. Acta Chir. Scand. 1976; 142: 187
   PubMedGoogle Scholar
• Wengeler H., Greten H., Seidel D. Serum cholesterol esterification in liver disease. Combined determination of lecithinolesterol acyltransferase and lipoprotein-X. Eur. J. Clin. Invest. 1972; 2: 372
   PubMed Web of Science ®Google Scholar
• Ritland S., Blomhoff J. P., Gjone E. Lecithinolesterol acyltransferase and lipoprotein-X in liver disease. Clin. Chim. Acta 1973; 49: 251
   PubMed Web of Science ®Google Scholar
• Miller J. P., Johnson K. A critical examination of the value of combined determinations of lecithinolesterol acyltransferase and lipoprotein-X in the differential diagnosis of liver disease. Clin. Chim. Acta 1976; 69: 81
   PubMedGoogle Scholar
• Rubies-Prat J., Ras M. R., Frison J. C., Masdeu S., Bacardi R. The clearance of lipoprotein-X in vitro, and effect of phospholipase A on serum lipoprotein-X. Clin. Chim. Acta 1977; 75: 117
   PubMedGoogle Scholar
• Ritland S., Stokke K. T., Gjone E. Changes in the concentration of lipoprotein-X during incubation of postheparin plasma from patients with familial lecithinolesterol acyltransferase (LCAT) deficiency. Clin. Chim. Acta 1976; 67: 63
   PubMedGoogle Scholar
• Ritland S., Sauar J., Holme R., Blomhoff J. P. The electrophoretic mobility of lipoprotein-X in postheparin plasma. Clin. Chim. Acta 1977; 75: 129
   PubMedGoogle Scholar
• Ritland S., Bergan A. Plasma concentration of lipoprotein-X (LP-X) in experimental bile duct obstruction. Scand. J. Gastroenterol. 1975; 10: 17
   PubMed Web of Science ®Google Scholar
• Muller P., Fellin R., Lambrecht J., Agostini B., Wieland H., Rost W., Seidel D. Hypertriglyceridaemia secondary to liver disease. Eur. J. Clin. Invest. 1974; 4: 419
   PubMed Web of Science ®Google Scholar
• Ober M., Witt I. Lipoprotein-X (LP-X) bei Neugeborenen: Gehäuftes Auftreten ohne nachweis bare cholestase. Jahrestagung der Deutschen, Österreichischen und, Schweizerischen Gessellschaft fur Klinische Chemie, Freiburg, West Germany March 16 to 18, 1975, (Abstract)
   Google Scholar
• Picard J., Veissiere D., Voyer F., Bereziat G. Composition en acides gras des phosphilipides dans les lipoproteines sériques anormales de la cholestase. Clin. Chim. Acta 1972; 36: 247
   PubMedGoogle Scholar
• Manzato E., Fellin R., Baggio G., Walch S., Neubeck W., Seidel D. Formation of lipoprotein-X. Its relationship to bile compounds. J. Clin. Invest. 1976; 57: 1248
   PubMed Web of Science ®Google Scholar